This is a fundamental analysis of UNH stock. Several data points are considered. It's noted that hedge funds consider UNH a top buy. Congressman Tim Moore recently purchased shares. Hedge funds made UNH their top buy in Q2 of 2025. The stock collapsed due to sky-rocketing medical costs, which hurts company profits. It has ongoing issues from prior years like rising Medicare Advantage plan costs, and the Department of Justice is investigating its Medicare Advantage program. However, the new CEO spent $25 million to buy UNH stock in May 2025, with the CFO spending an additional $5 million. The forward PE ratio screams undervalued. A squiggly chart is displayed to highlight return on invested capital, and the video's author says it shows free cash flow is going back up, so the business isn't dead. High, but the analyst says to look at Mansfield RSI which shows it’s underperforming its sector. Also to track the moving average lines; The $400 revenue company is not looking good. Profit probably won't grow until 2026. Analysts predict it could drop to $160. UNH owns Optum, a tech service arm which offers some stability. Bottom line, the recommendation is to set your stops.